MTPConnect

Posted on: 04/06/2026 The dust is now settling (sort of) on the Australian Government’s 2026-27 Federal Budget which, frustratingly, squibbed the opportunity for action on Australia’s antimicrobial resistance crisis. The timing is stark. At the same time we were combing through the budget papers for absent AMR initiatives, public health officials across Australia were working to contain an outbreak of the bacterial infection, diphtheria.

Posted on: 02/06/2026 The Queensland Drug Discovery Alliance (QDDA) Symposium held recently in Brisbane, was a testament to the robust ecosystem being built around world‑class discovery and development expertise. And for enabling new technologies such as New Approach Methodologies (NAMs).

Posted on: 26/05/2026 Heart failure (HF) affects more than 64 million people worldwide, including an estimated 144,000 Australian adults.1,2 While some people can manage the condition with lifestyle modifications, medication, or surgical intervention, for those with severe, end-stage HF, a heart transplant remains the gold standard treatment.

Posted on: 13/05/2026 MTPConnect is bringing you premier activities at this year’s BIO international Convention in San Diego from 18-25 June 2026. Register now! 18–19 June: MTPConnect’s BIO 2026 Site Visit Program for interested BIO delegates will include site visits to multinational and industry organisations, insight keynotes and exclusive networking events.

Posted on: 11/05/2026 Congratulations to the seven medtech companies who have completed our 2026 Pathway to Market program, to be procurement-ready. This program is helping to get more home-grown medtech products purchased and used by local hospitals and health services.

Posted on: 28/04/2026 What does it REALLY take to build impactful health tech? Join The WA Life Sciences Innovation Hub on 28 May for a special event delivered with Matilda Health exploring the journey from clinician to founder, building AI-enabled products at scale, and finding true product–market fit in healthcare. The event will feature Joanna Morris, CEO and Co‑founder of Matilda Health, Dr Jackie Rabec, Co‑founder and CPO at ThinkMD.ai and first product hire/former head of product at Heidi.

Posted on: 27/04/2026 We are celebrating the 2025-26 cohort of our Australian Clinical Entrepreneur Program! Good luck to this amazing group of clinical and healthcare professionals who have just finished this 12 month program. Our industry-leading innovation program that started back in 2022 has now seen 190+ clinicians from VIC, NSW and WA, upskilled across 4 cohorts.

Posted on: 24/04/2026 For approximately one third of the 589 million people living with any type of diabetes globally, insulin is a lifesaving therapy that helps to control blood sugar and reduce the complications of the condition.1,2 Constant fluctuations in blood sugar levels can lead to a range of complications range from acute low blood sugar (hypoglycaemia), high blood sugar (hyperglycaemia) and ketoacidosis, which can be life threatening if not treated urgently, to the long-term...

Posted on: 14/04/2026 Join MTPConnect SA Director Dana Bell for a fireside chat and networking evening on the hot topic, ‘Geopolitical SOS: Global realignment is redefining risk and opportunity for South Australia’s life sciences sector’. We’re living through a period of profound global realignment, where politics, economics, and innovation are more intertwined than ever. For South Australia’s life sciences and innovation ecosystem, these shifts present both risk and opportunity.

Posted on: 14/04/2026 On behalf of the Australian Medtech Manufacturing Alliance (AMMA), MTPConnect invites you to join the 2026 AMMA Medtech Showcase on 7 May 2026! At the heart of the event is a curated exhibition of Australian medtech companies, highlighting locally designed and manufactured technologies that support high-quality, advanced healthcare delivery.